Global Brand Lead, Rsv Toddler And Adult
Current
Sep 2024 - Present
AeroLeads people directory · profile
George Griffith Email & Phone Number
Global Brand Lead, RSV Toddler and Adult Vaccines
at
Sanofi
1 work email found
@gsk.com
LinkedIn matched
✓ Verified August 2026
4 data sources
Profile completeness 100%
Current company
Role
Global Brand Lead, RSV Toddler and Adult Vaccines
Location
Greater Philadelphia, United States
Who is George Griffith? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
George Griffith is listed as Global Brand Lead, RSV Toddler and Adult Vaccines at Sanofi, based in Greater Philadelphia, United States. AeroLeads shows a work email signal at gsk.com and a matched LinkedIn profile for George Griffith.
George Griffith previously worked as Global Brand Lead, RSV Toddler and Adult at Sanofi and Senior Vice President, Head of Global Commercial Strategy at Novavax. George Griffith holds Executive Education Program from The Wharton School.
Company email context
Email format at Sanofi
This section adds company-level context without repeating George Griffith's masked contact details.
ggriffith@gsk.com
76% confidence
AeroLeads found 1 current-domain work email signal for George Griffith. Compare company email patterns before reaching out.
Profile bio
About George Griffith
Commercial leader with over 21 years of vaccine and infectious disease experience in a variety of global and US roles of increasing responsibility at Merck, GSK, Pfizer, AstraZeneca, and Novavax.
Listed skills include Market Research, Vaccines, Analytics, Pharmaceutical Industry, and 14 others.
Current workplace
George Griffith's current company
Company context helps verify the profile and gives searchers a useful next step.
17 roles
George Griffith work experience
A career timeline built from the work history available for this profile.
Senior Vice President, Head Of Global Commercial Strategy
Apr 2023 - Aug 2024
Global Commercial Head, Flu Franchise (Flumist) & Rsv (Beyfortus) In Alliance With Sanofi
+Led the development and strategy of the world’s first ever self/home administered vaccine (FluMist) from raw concept to FDA filing (now FDA approved). Responsible for all AZ Senior Executive Team Committee reviews and approvals, human factors studies, external partnership assessments, packaging development, initial US launch plan, and Ex-US planning. +Global Commercial Head of Synagis from March 2021 to February 2022 (competition law required separation of role as part of my role as JSC voting member in Sanofi alliance). Led the repatriation of ex-US rights and launch as an AZ product in over 85+ countries which won prestigious AZ BBU Award. +Served as acting Global Project Leader for Flumist/Fluenz from March 2021 to May 2022
Mar 2021 - Apr 2023
Global Commercial Lead, Supportive Care Oncology Biosimilars Portfolio
Global Commercial lead for the supportive care oncology biosimilars portfolio (Retacrit, Nivestim/Nivestym, and Nyvepria PFS) including commercial development for pegfilgrastim on body injector (OBI) development program.
Apr 2019 - Mar 2021
U.S. Marketing Lead, Prevnar13 Adult
U.S. marketing lead responsible for overall brand strategy and execution across all channels and segments.
Jan 2017 - Apr 2019
Pfizer Global Health Team - Special Assignment In India
Selected by senior management to serve on Pfizer’s first ever Global Health Team for a one month assignment in India to make strategic recommendations on a key public/private mass vaccination program.
May 2018 - May 2018
U.S. Commercial Strategy Lead, Prevnar13 Franchise
Led the market access strategy, CDC/ACIP planning team (co-led with Medical team), and long range strategy and operating plan for Prevnar.
Jan 2016 - Jan 2017
Area Sales Director, Specialty Sales
Led a team of ten sales representatives for specialty products in Philadelphia area.
Jun 2015 - Jan 2016
Global Commercial Lead, Shingrix - International Assignment
Selected for international assignment to lead the commercial development strategy and delivery of the global launch plan for Shingrix.
Jul 2012 - Jun 2015
Director, Vaccine Market Access
Responsible for U.S. pricing reccomendations, generating payer market insights, developing high-impact reimbursement access strategies, and developing field facing reimbursement solutions in preparation of launches (QIV Flu, Boostrix, and Menhibrix).
Feb 2012 - Jul 2012
Senior Manager, Vaccine Market Access
Recruited to newly created payer marketing team to support multiple product launches (QIV Flu, Boostrix, and Menhibrix).
Mar 2011 - Feb 2012
Associate Manager, Infectious Disease Market Access (Hiv, Hep C, Vaccines)
Developed and implemented market access strategies and tactics for key vaccine and infectious disease product launches (Zostavax 50-59, Gardasil, Isentress, and Victrelis) focused on removing reimbursement barriers to drive rapid utilization.
May 2009 - Mar 2011
Senior Business Analyst, Us Vaccine/Pharma Commercial Operations
Designed and implemented the national roll out of new field force sales incentive compensation metrics across all US business units as part of Merck’s new commercial model.
Jun 2008 - May 2009
Business Analyst, Vaccine Commercial Strategy
Responsible for assessing and delivering strategic recommendations for key vaccine business opportunities across brands impacting vaccine commercial model, distribution strategy, market share defense strategies, and contracting/pricing strategies.
Jan 2007 - Jun 2008
Vaccine Sales Representative, Vaccine Portfolio And Launch Products
Launched two products (Zostavax and Gardasil) and drove sales for entire vaccine portfolio in offices, hospitals, and IDNs. Ranked as one of top sales reps in the country.
May 2006 - Jan 2007
Pre-Licensure Market Development, Zoster And Hpv Vaccines
Pre-launch market shaping for HPV and Zoster vaccine launches by establishing key relationships with key thought leaders, providers, and local/regional institutions.
Oct 2005 - May 2006
Pharmaceutical Sales Representative, Pain/Respiratory/Cardiovascular
Drove sales and market share growth for products across cardiovascular, respiratory, pain, and endocrinology therapeutic areas. Top Performer.
Jul 2003 - Oct 2005
4 education records
George Griffith education
Executive Education Program
The Wharton School
Mba, International Business
W. P. Carey School Of Business – Arizona State University
B.S.J., Public Relations
West Virginia University
Education record
Trinity-Pawling School
FAQ
Frequently asked questions about George Griffith
Quick answers generated from the profile data available on this page.
What company does George Griffith work for?
George Griffith works for Sanofi.
What is George Griffith's role at Sanofi?
George Griffith is listed as Global Brand Lead, RSV Toddler and Adult Vaccines at Sanofi.
What is George Griffith's email address?
AeroLeads has found 1 work email signal at @gsk.com for George Griffith at Sanofi.
Where is George Griffith based?
George Griffith is based in Greater Philadelphia, United States while working with Sanofi.
What companies has George Griffith worked for?
George Griffith has worked for Sanofi, Novavax, Astrazeneca, Pfizer, and Gsk Us.
How can I contact George Griffith?
You can use AeroLeads to view verified contact signals for George Griffith at Sanofi, including work email, phone, and LinkedIn data when available.
What schools did George Griffith attend?
George Griffith holds Executive Education Program from The Wharton School.
What skills is George Griffith known for?
George Griffith is listed with skills including Market Research, Vaccines, Analytics, Pharmaceutical Industry, Pharmaceutical Sales, Biotechnology, Product Launch, and Sales Effectiveness.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial